Rafferty Asset Management’s CARGO Therapeutics CRGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-32,812
Closed -$473K 1085
2024
Q4
$473K Buy
32,812
+5,161
+19% +$93.7K ﹤0.01% 925
2024
Q3
$510K Sell
27,651
-12,806
-32% -$229K ﹤0.01% 923
2024
Q2
$664K Sell
40,457
-7,129
-15% -$136K ﹤0.01% 891
2024
Q1
$1.06M Buy
+47,586
New +$1.13M ﹤0.01% 824

Other funds holding CRGX

Rafferty Asset Management's CRGX Position: Q1 2025 in Review

Rafferty Asset Management sold out of CARGO Therapeutics (CRGX) in Q1 2025, closing a stake of 32,812 shares — an estimated $473K sold.

Rafferty Asset Management first reported a position in CRGX in Q1 2024 and held it in 4 quarters. The position peaked at $1.06M in Q1 2024. 113 funds tracked by Wall St. Rank hold CRGX as of Q1 2025.

  • Rafferty Asset Management reported no remaining CARGO Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Rafferty Asset Management sold 32,812 CARGO Therapeutics shares in Q1 2025, an estimated $473K.
  • Rafferty Asset Management first reported a position in CARGO Therapeutics in Q1 2024 and held it in 4 quarters.
  • Rafferty Asset Management's CARGO Therapeutics position peaked at $1.06M in Q1 2024.
  • 113 funds tracked by Wall St. Rank held CARGO Therapeutics as of Q1 2025.

Based on Rafferty Asset Management's 13F filing for Q1 2025, filed 14 May 2025.